KELLY ANTIMISIARIS: Open Payments
NPI 1265213797 · MASSAPEQUA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,580 in 131 payments from 19 companies in 2025. Trend: 2023 $83 · 2024 $2,395 · 2025 $2,580
Food & beverage: $2,580
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 25 | $498 |
| Janssen Pharmaceuticals, Inc | 11 | $327 |
| ABBVIE INC. | 12 | $278 |
| Corium, LLC | 16 | $222 |
| Supernus Pharmaceuticals, Inc. | 13 | $195 |
| Teva Pharmaceuticals USA, Inc. | 11 | $173 |
| Alkermes, Inc. | 10 | $171 |
| Bausch Health US, LLC | 6 | $124 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
Products named: REXULTI, SPRAVATO, VRAYLAR, Azstarys, Qelbree, ARISTADA, APLENZIN, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
